Research study Program year 2023 Source: CMS Open Payments

P3 AD Vaccine Study

Research payments

$103,341

32 payments

Through program year 2023, $103,341 in research payments was reported against P3 AD Vaccine Study, across 32 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2023	Research	$103,341	32

Breakdown

Who paid Research payments · program year 2023

Amgen Inc. $103,341 32 payments

Who received the money Research payments · program year 2023

Integrative Skin Sci & Rsrch Organisation paid for research $14,172 1 payment
The Skin Surgery Center Organisation paid for research $12,598 1 payment
Excel Clinical Research Organisation paid for research $8,661 1 payment
Anchor Medical Research Organisation paid for research $7,677 1 payment
Sms Clin Rsrch LLC Organisation paid for research $6,496 1 payment
Long Beach Research Institute Organisation paid for research $4,724 1 payment
Hope Clinical Research LLC Organisation paid for research $3,740 1 payment
Apex Clinical Research Center LLC Organisation paid for research $3,543 1 payment
Las Vegas Clinical Trials Organisation paid for research $3,543 1 payment
Cumberland Skin Center Organisation paid for research $3,346 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.